Article ID Journal Published Year Pages File Type
4232465 Journal of the American College of Radiology 2008 6 Pages PDF
Abstract
In 1997, a new fibrosing skin disorder became apparent among patients with renal disease. Nephrogenic systemic fibrosis, as this disorder has come to be known, has recently been tied to the administration of contrast agents containing gadolinium. This overview examines the discovery and elucidation of the major research accomplishments to date. It was presented as the keynote address at the First Annual Scientific Symposium on Nephrogenic Systemic Fibrosis and MRI Contrast, conducted at Yale University on May 4, 2007.
Related Topics
Health Sciences Medicine and Dentistry Radiology and Imaging
Authors
,